ArticleThe Journal of urology2026

Cost-Effectiveness of Immune Checkpoint Inhibitor Therapy Plus Bacillus Calmette-Guérin for High-Risk Nonmuscle-Invasive Bladder Cancer: Analyses of CREST, POTOMAC, and ALBAN.

Daniel D Joyce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.